{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T06:40:01Z","timestamp":1756017601035,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL077478"],"award-info":[{"award-number":["HL077478"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.hrthm.2025.04.066","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:27:42Z","timestamp":1746725262000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors and outcomes associated with failed implantable cardioverter-defibrillator shocks"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6082-535X","authenticated-orcid":false,"given":"Amole","family":"Ojo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"McNitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet K.","family":"Akta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2025.04.066_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.04.066_bib2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.04.066_bib3","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/jce.12699","article-title":"Shock reduction with multiple bursts of antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: a multicenter study","volume":"26","author":"Anguera","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.04.066_bib4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/pace.14002","article-title":"Do ICD diagnostics predict failure of ventricular tachycardia response to antitachycardia pacing and need for shock?","volume":"43","author":"Al-Damluji","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.04.066_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.hrthm.2022.10.015","article-title":"Antitachycardia pacing success in implantable cardioverter-defibrillators by patient, device, and programming characteristics","volume":"20","author":"Sterns","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.04.066_bib6","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.hrthm.2024.08.055","article-title":"Failure to treat ventricular tachycardia or ventricular fibrillation by implantable cardioverter-defibrillators","volume":"22","author":"Hauser","year":"2025","journal-title":"Heart Rhythm"},{"year":"2011","series-title":"Risk Stratification in MADIT II Type Patients","author":"Zareba","key":"10.1016\/j.hrthm.2025.04.066_bib7"},{"key":"10.1016\/j.hrthm.2025.04.066_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.04.066_bib9","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.04.066_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2018.04.086","article-title":"Ranolazine in high-risk patients with implanted cardioverter-defibrillators: the RAID trial","volume":"72","author":"Zareba","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.04.066_bib11","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.7326\/M22-1566","article-title":"Perioperative safety and early patient and device outcomes among subcutaneous versus transvenous implantable cardioverter defibrillator implantations : a randomized, multicenter trial","volume":"175","author":"Healey","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2025.04.066_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10840-018-0443-y","article-title":"Single and dual coil shock efficacy and predictors of shock failure in patients with modern implantable cardioverter defibrillators-a single-center paired randomized study","volume":"54","author":"Larsen","year":"2019","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.04.066_bib13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.hrthm.2023.03.017","article-title":"Failed shocks in patients with hypertrophic cardiomyopathy","volume":"20","author":"Segev","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.04.066_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.amjcard.2022.04.027","article-title":"Comparison of frequency of ventricular tachyarrhythmia in men-versus-women in patients with implantable cardioverter-defibrillator for primary prevention","volume":"176","author":"Ojo","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2025.04.066_bib15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1210\/en.2003-0816","article-title":"Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A","volume":"145","author":"Li","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.hrthm.2025.04.066_bib16","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/europace\/euv313","article-title":"Sex-dependent alterations of Ca2+ cycling in human cardiac hypertrophy and heart failure","volume":"18","author":"Fischer","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.04.066_bib17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jacep.2022.11.020","article-title":"Age and the risk of ventricular tachyarrhythmia in patients with an implantable cardioverter-defibrillator","volume":"9","author":"Akta\u015f","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.04.066_bib18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa2409501","article-title":"Catheter ablation or antiarrhythmic drugs for ventricular tachycardia","volume":"392","author":"Sapp","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.04.066_bib19","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.jacc.2021.03.329","article-title":"Survival after implantable cardioverter-defibrillator shocks","volume":"77","author":"Akta\u015f","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.04.066_bib20","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2013.04.083","article-title":"Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study","volume":"62","author":"Powell","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.04.066_bib21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.04.066_bib22","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.hrthm.2011.07.036","article-title":"Shocks burden and increased mortality in implantable cardioverter-defibrillator patients","volume":"8","author":"Larsen","year":"2011","journal-title":"Heart Rhythm"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154752712502418X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154752712502418X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T06:23:03Z","timestamp":1756016583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154752712502418X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":22,"alternative-id":["S154752712502418X"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.04.066","relation":{},"ISSN":["1547-5271"],"issn-type":[{"type":"print","value":"1547-5271"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and outcomes associated with failed implantable cardioverter-defibrillator shocks","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.04.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}